$19.13+$6.13 (+47.15%)in 1 year

As on 13 Nov 2026 at 02:29NASDAQ

Vogenx Share Price Today

Vogenx opened lower at $20.66, compared with its previous close of $20.77. In the last trading session, the stock traded between $18.67 and $20.80. It showed a downward intraday trend.

Return calculator

You have invested

Time Period

An investment of $100 made 1 year ago in Vogenx is now worth

$ 147.15

Giving a profit of

$ 47.15 (47.15%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Rating from 1 Analysts

Buy

100%

Hold

Sell

Markets Today

Today's Change

$-1.64 (-7.90%)

Day High

$20.80

Day Low

$18.67

Day Open

$20.66

Prev Close

$20.77

Volume

96,921

1W Return

-2.45%

1M Return

10.39%

3M Return

47.15%

6M Return

47.15%

1Y Return

47.15%

Fundamentals

Market Cap ($ Mn)

PE Ratio

PB Ratio

PEG Ratio

ROE

ROCE

EPS (TTM)

Investment Returns

1 Week

-2.45%

1 Month

10.39%

3 Months

47.15%

6 Months

47.15%

9 Months

47.15%

Financials

Quarterly

All values in $ Mn

0.0

Mar 25

0.0

Jun 25

0.0

Mar 26

0.0

Jun 26

Updates

6Nov

Vogenx Q3FY26 Results: EPS misses estimate, net loss widens to $4.9 million

Net loss widened to $4.9 million from $284 thousand YoY. Loss per share of $(0.47) missed analyst estimate of $(0.09) by 422%. Warrant liability change of $3.4 million drove majority of net loss. Cash position strengthened to $82.1 million following August IPO.

6 days ago

16Oct

Vogenx initiates Phase 2b EMERGE study for post-bariatric hypoglycemia

Vogenx Inc initiated Phase 2b EMERGE trial for post-bariatric hypoglycemia. Study evaluates mizagliflozin doses of 5 mg and 10 mg against placebo. Trial enrolls approximately 36 adults with prior bariatric surgery. No FDA-approved therapeutics currently exist for this condition.

28 days ago

Similar Stocks

Stock	LTP	Change %	Market Cap	PE
V Vertex Pharmaceuticals	$547.03	-0.16%	$1,38,692.89M	31.55
B British American Tobacco	$61.05	+0.38%	$1,31,510.31M	14.39
M Moderna	$248.69	-0.85%	$1,00,625.20M	-
R Regeneron Pharmaceuticals	$959.41	+4.73%	$97,505.80M	19.64
A Argen X SE - ADR	$977.58	+0.62%	$61,476.10M	38.99
O BeOne Medicines - ADR	$419.98	-0.95%	$46,108.31M	65.60
R Revolution Medicines	$180.70	-6.40%	$39,083.96M	-
G Genmab	$53.87	-0.37%	$33,618.11M	26.24
R Royalty Pharma - Class A	$70.01	+0.81%	$31,173.07M	32.37
R Roivant Sciences	$41.85	+1.60%	$30,322.88M	-
I Insmed	$120.75	+1.05%	$26,490.14M	-
I Incyte	$122.27	+1.64%	$24,922.54M	15.85